Literature DB >> 19272789

Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience.

Nabil Saouti1, Wim J Morshuis, Robin H Heijmen, Repke J Snijder.   

Abstract

OBJECTIVE: Pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) is the first treatment of choice with good short-term results. Only limited data are available concerning the long-term outcome after PEA. The purpose of this study is to evaluate the long-term survival and functional outcome after PEA with nearly 10 years experience.
METHOD: In the period of December 1998 and December 2007 120 patients with CTEPH were referred to the St Antonius Hospital (Nieuwegein, The Netherlands) of whom 72 underwent PEA. The clinical data are collected retrospectively.
RESULTS: In-hospital mortality was (5/72) 6.9%. Since 2004 one patient died in the hospital (1/38, 2.9%). Two patients died during long-term follow-up with a median observation of 3 years. The overall 1-, 3- and 5-year survival rates were 93.1%, 91.2% and 88.7% respectively. Prior to surgery patients were in New York Heart Association functional class III (58) and IV (14) with a mean pulmonary vascular resistance of 572+/-313 dynes s cm(-5). The following data were compared before and after operation: mean pulmonary artery pressure (mPAP) decreased from 42+/-11 to 22+/-7 mmHg (p=0.0001), NT-pro BNP improved from 1527+/-1652 to 160+/-3 pg/ml (p=0.0001), 6 min walk distance (6MWD) from 359+/-124 to 518+/-11 m (p=0.0001), and almost all patients returned to functional class I or II (p=0.0001).
CONCLUSION: Pulmonary endarterectomy for patients with CTEPH has shown a dramatic improvement of clinical status with excellent long-term survival.

Entities:  

Mesh:

Year:  2009        PMID: 19272789     DOI: 10.1016/j.ejcts.2009.01.023

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  18 in total

1.  Pulmonary endarterectomy surgery--a technically demanding cure for WHO Group IV Pulmonary Hypertension: requirements for centres of excellence and availability in Canada.

Authors:  John J Ryan; Stuart Rich; Stephen L Archer
Journal:  Can J Cardiol       Date:  2011-10-22       Impact factor: 5.223

2.  Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.

Authors:  John E Cannon; Li Su; David G Kiely; Kathleen Page; Mark Toshner; Emilia Swietlik; Carmen Treacy; Anie Ponnaberanam; Robin Condliffe; Karen Sheares; Dolores Taboada; John Dunning; Steven Tsui; Choo Ng; Deepa Gopalan; Nicholas Screaton; Charlie Elliot; Simon Gibbs; Luke Howard; Paul Corris; James Lordan; Martin Johnson; Andrew Peacock; Robert MacKenzie-Ross; Benji Schreiber; Gerry Coghlan; Kostas Dimopoulos; Stephen J Wort; Sean Gaine; Shahin Moledina; David P Jenkins; Joanna Pepke-Zaba
Journal:  Circulation       Date:  2016-04-06       Impact factor: 29.690

3.  Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH).

Authors:  Sebastian Ley; Julia Ley-Zaporozhan; Michael B Pitton; Jens Schneider; Gesine M Wirth; Eckhard Mayer; Christoph Düber; Karl-Friedrich Kreitner
Journal:  Eur Radiol       Date:  2011-09-27       Impact factor: 5.315

4.  Prediction of hemodynamic improvement after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension using non-invasive imaging.

Authors:  Bastiaan E Schölzel; Martijn C Post; Alexander van de Bruaene; Steven Dymarkowski; Wim Wuyts; Bart Meyns; Werner Budts; Marion Delcroix
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-22       Impact factor: 2.357

5.  Clinical worsening after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

Authors:  B Schölzel; R Snijder; W Morshuis; N Saouti; T Plokker; M Post
Journal:  Neth Heart J       Date:  2011-12       Impact factor: 2.380

6.  Residual pulmonary hypertension after retrograde pulmonary embolectomy: long-term follow-up of 30 patients with massive and submassive pulmonary embolism.

Authors:  Khalil Zarrabi; Abdolali Zolghadrasli; Mohammad Ali Ostovan; Azimeh Azimifar; Leila Malekmakan
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-14

Review 7.  Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.

Authors:  David S Poch; William R Auger
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 8.  Recent advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension including Japanese experiences.

Authors:  Hitoshi Ogino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-09-26

Review 9.  Respiratory and hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension 1 year after pulmonary endarterectomy.

Authors:  Masato Sato; Motomi Ando; Kan Kaneko; Yoshiro Higuchi; Hiroshi Kondo; Kiyotoshi Akita; Michiko Ishida; Yasushi Takagi
Journal:  Ann Vasc Dis       Date:  2013-08-12

Review 10.  Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Liyan Zhang; Yuping Bai; Peijing Yan; Tingting He; Bin Liu; Shanlian Wu; Zhen Qian; Changtian Li; Yunshan Cao; Min Zhang
Journal:  Heart Fail Rev       Date:  2021-02-05       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.